questionText: To ask the Secretary of State for Health and Social Care, if he will commission research to (a) track and (b) compare international access to myeloma treatments; whether his Department holds data on the use by other countries of isatuximab in combination with pomalidomide and dexamethasone for the treatment of myeloma patients; and when he expects NICE to publish its final guidance on the use of isatuximab with pomalidomide and dexamethasone in the treatment of such patients.
answerText: The Department has no plans to commission research to compare international access to myeloma treatments. There are a number of independent publications that compare international access to new medicines, including cancer medicines, such as the European F...
heading: Multiple Myeloma: Medical Treatments